SE526919C8 - Nukleinsyra (IIP) som kodar för en IGF-1 receptorbindande polypeptid samt användning därav i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera föreningar som inhiberar interaktionen mellan IIP-1 och IGF-1R - Google Patents
Nukleinsyra (IIP) som kodar för en IGF-1 receptorbindande polypeptid samt användning därav i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera föreningar som inhiberar interaktionen mellan IIP-1 och IGF-1RInfo
- Publication number
- SE526919C8 SE526919C8 SE0301757A SE0301757A SE526919C8 SE 526919 C8 SE526919 C8 SE 526919C8 SE 0301757 A SE0301757 A SE 0301757A SE 0301757 A SE0301757 A SE 0301757A SE 526919 C8 SE526919 C8 SE 526919C8
- Authority
- SE
- Sweden
- Prior art keywords
- iip
- igf
- inhibit
- encoding
- interaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98122992A EP1006184A1 (en) | 1998-12-03 | 1998-12-03 | IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
SE0301757D0 SE0301757D0 (sv) | 2003-06-18 |
SE526919C2 SE526919C2 (sv) | 2005-11-15 |
SE526919C8 true SE526919C8 (sv) | 2005-12-14 |
Family
ID=8233086
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9904389A SE523013C2 (sv) | 1998-12-03 | 1999-12-02 | Nukleinsyra (IIP-10) som kodar för en IGF-1-receptorbindande polypeptid samt användning av nukleinsyran eller polypeptiden i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera ämnen som modulerar interaktionen mellan IIP-10 och IGF-1R |
SE0301757A SE526919C8 (sv) | 1998-12-03 | 2003-06-18 | Nukleinsyra (IIP) som kodar för en IGF-1 receptorbindande polypeptid samt användning därav i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera föreningar som inhiberar interaktionen mellan IIP-1 och IGF-1R |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9904389A SE523013C2 (sv) | 1998-12-03 | 1999-12-02 | Nukleinsyra (IIP-10) som kodar för en IGF-1-receptorbindande polypeptid samt användning av nukleinsyran eller polypeptiden i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera ämnen som modulerar interaktionen mellan IIP-10 och IGF-1R |
Country Status (13)
Country | Link |
---|---|
US (6) | US6368826B1 (sv) |
EP (1) | EP1006184A1 (sv) |
JP (3) | JP3294575B2 (sv) |
AU (1) | AU728102B2 (sv) |
BE (1) | BE1013527A3 (sv) |
CA (1) | CA2289914C (sv) |
CH (1) | CH694204A5 (sv) |
DE (3) | DE19958198B4 (sv) |
FR (1) | FR2788783B1 (sv) |
GB (1) | GB2347930B (sv) |
IT (1) | IT1314250B1 (sv) |
NL (1) | NL1013748C2 (sv) |
SE (2) | SE523013C2 (sv) |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197582B1 (en) * | 1998-03-18 | 2001-03-06 | The Trustees Of Columbia University In The City Of New York | Development of human monoclonal antibodies and uses thereof |
US7060802B1 (en) * | 2000-09-18 | 2006-06-13 | The Trustees Of Columbia University In The City Of New York | Tumor-associated marker |
US7638605B2 (en) * | 2003-05-01 | 2009-12-29 | ImClone, LLC | Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
MY146381A (en) * | 2004-12-22 | 2012-08-15 | Amgen Inc | Compositions and methods relating relating to anti-igf-1 receptor antibodies |
CA2612449A1 (en) | 2005-06-17 | 2006-12-28 | Imclone Systems Incorporated | Receptor antagonists for treatment of metastatic bone cancer |
DK1926996T3 (da) * | 2005-09-20 | 2012-01-23 | Osi Pharmaceuticals Llc | Biologiske markører, som er prædiktive for anti-cancer-reaktion på insulinlignende vækstfaktor-1-receptorkinasehæmmere |
CN101484587B (zh) * | 2006-02-03 | 2014-02-12 | 英克隆有限责任公司 | Igf-ir拮抗剂作为辅药用于***癌的治疗 |
US20070245980A1 (en) * | 2006-03-27 | 2007-10-25 | Phillips Terry G | Water heating systems and methods |
WO2008065636A2 (en) * | 2006-12-01 | 2008-06-05 | University College York - National University Of Ireland, Cork | Treatment of disease by modulating cf5 protein |
WO2008079849A2 (en) * | 2006-12-22 | 2008-07-03 | Genentech, Inc. | Antibodies to insulin-like growth factor receptor |
ES2707551T3 (es) * | 2007-03-02 | 2019-04-04 | Amgen Inc | Métodos y composiciones para tratar enfermedades tumorales |
MX2010002249A (es) * | 2007-08-31 | 2010-03-17 | Amgen Inc | Formulacion de proteina de estado solido. |
US8383114B2 (en) * | 2007-09-27 | 2013-02-26 | Amgen Inc. | Pharmaceutical formulations |
EP3381445B1 (en) | 2007-11-15 | 2023-10-25 | Amgen Inc. | Aqueous formulation of antibody stablised by antioxidants for parenteral administration |
US20100316639A1 (en) | 2009-06-16 | 2010-12-16 | Genentech, Inc. | Biomarkers for igf-1r inhibitor therapy |
WO2011050333A1 (en) | 2009-10-23 | 2011-04-28 | Amgen Inc. | Vial adapter and system |
ME02206B (me) * | 2010-05-27 | 2016-02-20 | Centocor Ortho Biotech Inc | Receptor insulinu-sličnog faktora rasta 1 vezujući peptidi |
ES2545411T5 (es) | 2010-06-07 | 2024-04-05 | Amgen Inc | Dispositivo de administración de fármaco |
JP2014510265A (ja) | 2011-02-02 | 2014-04-24 | アムジェン インコーポレイテッド | Igf−1rの阻害に関する方法および組成物 |
MX341790B (es) | 2011-03-31 | 2016-09-02 | Amgen Inc | Adaptador de viales y sistema. |
AU2012245231B2 (en) | 2011-04-20 | 2016-10-13 | Amgen Inc. | Autoinjector apparatus |
CN103930142B (zh) | 2011-10-14 | 2016-12-14 | 安姆根有限公司 | 注射器和装配方法 |
AU2012335541B2 (en) | 2011-11-11 | 2017-07-06 | Duke University | Combination drug therapy for the treatment of solid tumors |
US8980259B2 (en) | 2012-07-20 | 2015-03-17 | Novartis Ag | Combination therapy |
SI3081249T1 (sl) | 2012-11-21 | 2021-03-31 | Amgen Inc. | Naprava za dajanje zdravila |
CA2904725C (en) | 2013-03-15 | 2022-04-12 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
JP6768501B2 (ja) | 2013-03-15 | 2020-10-14 | アムゲン・インコーポレーテッド | 薬物カセット、自動注入機、および自動注入機システム |
WO2014149357A1 (en) | 2013-03-22 | 2014-09-25 | Amgen Inc. | Injector and method of assembly |
PL3060275T3 (pl) | 2013-10-24 | 2019-12-31 | Amgen Inc. | Wstrzykiwacz i sposób montażu |
EP3060281B1 (en) | 2013-10-24 | 2019-01-30 | Amgen Inc. | Drug delivery system with temperature-sensitive control |
WO2015119906A1 (en) | 2014-02-05 | 2015-08-13 | Amgen Inc. | Drug delivery system with electromagnetic field generator |
AU2015256082C1 (en) | 2014-05-07 | 2020-09-10 | Amgen Inc. | Autoinjector with shock reducing elements |
CN112237662B (zh) | 2014-06-03 | 2022-10-21 | 安姆根有限公司 | 药物递送***和使用方法 |
AU2015332557B2 (en) | 2014-10-14 | 2020-05-14 | Amgen Inc. | Drug injection device with visual and audio indicators |
JP6716566B2 (ja) | 2014-12-19 | 2020-07-01 | アムジエン・インコーポレーテツド | 近接センサ付き薬物送達装置 |
ES2785311T3 (es) | 2014-12-19 | 2020-10-06 | Amgen Inc | Dispositivo de administración de fármacos con botón móvil o campo de interfaz de usuario |
CA2976935C (en) | 2015-02-17 | 2020-03-10 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
ES2905870T3 (es) | 2015-02-27 | 2022-04-12 | Amgen Inc | Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja |
WO2017039786A1 (en) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Syringe assembly adapter for a syringe |
WO2017100501A1 (en) | 2015-12-09 | 2017-06-15 | Amgen Inc. | Auto-injector with signaling cap |
WO2017120178A1 (en) | 2016-01-06 | 2017-07-13 | Amgen Inc. | Auto-injector with signaling electronics |
WO2017129763A1 (en) | 2016-01-28 | 2017-08-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of signet ring cell gastric cancer |
EP3429663B1 (en) | 2016-03-15 | 2020-07-15 | Amgen Inc. | Reducing probability of glass breakage in drug delivery devices |
WO2017189089A1 (en) | 2016-04-29 | 2017-11-02 | Amgen Inc. | Drug delivery device with messaging label |
WO2017192287A1 (en) | 2016-05-02 | 2017-11-09 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
MX2018013616A (es) | 2016-05-13 | 2019-02-21 | Amgen Inc | Montaje de cubierta protectora de vial. |
US11238150B2 (en) | 2016-05-16 | 2022-02-01 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
WO2017209899A1 (en) | 2016-06-03 | 2017-12-07 | Amgen Inc. | Impact testing apparatuses and methods for drug delivery devices |
WO2018004842A1 (en) | 2016-07-01 | 2018-01-04 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
US20190328965A1 (en) | 2016-08-17 | 2019-10-31 | Amgen Inc. | Drug delivery device with placement detection |
EP3532127A1 (en) | 2016-10-25 | 2019-09-04 | Amgen Inc. | On-body injector |
AU2018210301A1 (en) | 2017-01-17 | 2019-08-01 | Amgen Inc. | Injection devices and related methods of use and assembly |
MX2019009755A (es) | 2017-02-17 | 2019-10-07 | Amgen Inc | Mecanismo de insercion para dispositivo de suministro de farmacos. |
WO2018151890A1 (en) | 2017-02-17 | 2018-08-23 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
EP3592403A1 (en) | 2017-03-06 | 2020-01-15 | Amgen Inc. | Drug delivery device with activation prevention feature |
IL268478B2 (en) | 2017-03-07 | 2023-10-01 | Amgen Inc | Inserting a needle using super pressure |
IL268386B2 (en) | 2017-03-09 | 2023-11-01 | Amgen Inc | Insertion mechanism for a drug delivery device |
EP4241807A3 (en) | 2017-03-28 | 2023-10-11 | Amgen Inc. | Plunger rod and syringe assembly system and method |
AU2018282077B2 (en) | 2017-06-08 | 2023-11-23 | Amgen Inc. | Torque driven drug delivery device |
AU2018280054B2 (en) | 2017-06-08 | 2023-07-13 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
US11541183B2 (en) | 2017-06-22 | 2023-01-03 | Amgen Inc. | Device activation impact/shock reduction |
JP7475860B2 (ja) | 2017-06-23 | 2024-04-30 | アムジエン・インコーポレーテツド | スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス |
ES2972207T3 (es) | 2017-07-14 | 2024-06-11 | Amgen Inc | Sistema de inserción-retracción de agujas con sistema de resorte de torsión doble |
MA49626A (fr) | 2017-07-21 | 2020-05-27 | Amgen Inc | Élément d'étanchéité perméable aux gaz pour récipient à médicament et procédés d'assemblage |
EP4085942A1 (en) | 2017-07-25 | 2022-11-09 | Amgen Inc. | Drug delivery device with gear module and related method of assembly |
EP3658206A1 (en) | 2017-07-25 | 2020-06-03 | Amgen Inc. | Drug delivery device with container access system and related method of assembly |
EP3664863A2 (en) | 2017-08-09 | 2020-06-17 | Amgen Inc. | Hydraulic-pneumatic pressurized chamber drug delivery system |
EP3668567A1 (en) | 2017-08-18 | 2020-06-24 | Amgen Inc. | Wearable injector with sterile adhesive patch |
US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
WO2019070472A1 (en) | 2017-10-04 | 2019-04-11 | Amgen Inc. | FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE |
IL272636B1 (en) | 2017-10-06 | 2024-06-01 | Amgen Inc | Drug delivery device with combination assembly and related assembly method |
WO2019074579A1 (en) | 2017-10-09 | 2019-04-18 | Amgen Inc. | DRUG DELIVERY DEVICE COMPRISING A DRIVE ASSEMBLY AND ASSEMBLY METHOD THEREOF |
EP3703778A1 (en) | 2017-11-03 | 2020-09-09 | Amgen Inc. | System and approaches for sterilizing a drug delivery device |
WO2019089178A1 (en) | 2017-11-06 | 2019-05-09 | Amgen Inc. | Drug delivery device with placement and flow sensing |
WO2019090303A1 (en) | 2017-11-06 | 2019-05-09 | Amgen Inc. | Fill-finish assemblies and related methods |
SG11202002966QA (en) | 2017-11-10 | 2020-05-28 | Amgen Inc | Plungers for drug delivery devices |
SG11202002772VA (en) | 2017-11-16 | 2020-04-29 | Amgen Inc | Autoinjector with stall and end point detection |
IL273638B1 (en) | 2017-11-16 | 2024-06-01 | Amgen Inc | Door lock mechanism for drug delivery device |
US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
WO2020023336A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with grip portion |
WO2020023220A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation |
US12042645B2 (en) | 2018-07-24 | 2024-07-23 | Amgen Inc. | Delivery devices for administering drugs |
MX2021000749A (es) | 2018-07-24 | 2021-03-29 | Amgen Inc | Dispositivos de suministro para administrar farmacos. |
WO2020028009A1 (en) | 2018-07-31 | 2020-02-06 | Amgen Inc. | Fluid path assembly for a drug delivery device |
US20210346601A1 (en) | 2018-09-24 | 2021-11-11 | Amgen Inc. | Interventional dosing systems and methods |
CA3110371A1 (en) | 2018-09-28 | 2020-04-02 | Amgen Inc. | Muscle wire escapement activation assembly for a drug delivery device |
EP3860685A1 (en) | 2018-10-02 | 2021-08-11 | Amgen Inc. | Injection systems for drug delivery with internal force transmission |
EP3860686A1 (en) | 2018-10-05 | 2021-08-11 | Amgen Inc. | Drug delivery device having dose indicator |
CA3109988A1 (en) | 2018-10-15 | 2020-04-23 | Amgen Inc. | Platform assembly process for drug delivery device |
MA53912A (fr) | 2018-10-15 | 2022-01-19 | Amgen Inc | Dispositif d'administration de médicament comprenant un mécanisme d'amortissement |
TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
CA3113076A1 (en) | 2018-11-01 | 2020-05-07 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
US11213620B2 (en) | 2018-11-01 | 2022-01-04 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
MX2021012557A (es) | 2019-04-24 | 2021-11-12 | Amgen Inc | Conjuntos y metodos de verificacion de esterilizacion de jeringuillas. |
MX2022002149A (es) | 2019-08-23 | 2022-03-17 | Amgen Inc | Dispositivo de suministro de farmacos con componentes de acoplamiento de capuchon de aguja configurable y metodos relacionados. |
US20240208680A1 (en) | 2021-05-21 | 2024-06-27 | Amgen Inc. | Method of optimizing a filling recipe for a drug container |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2915082A (en) | 1956-12-03 | 1959-12-01 | Evart V Shaw | Automobile beverage container assembly |
CA1219824A (en) | 1981-04-17 | 1987-03-31 | David C. Ward | Modified nucleotides and methods of preparing and using same |
JPH0743376B2 (ja) | 1983-05-31 | 1995-05-15 | オルジェニックス リミテッド | 核酸配列の検定方法及び分子遺伝子プローブ |
DE3431536A1 (de) | 1984-08-28 | 1986-03-13 | Boehringer Mannheim Gmbh, 6800 Mannheim | Derivatisierte nucleinsaeure-sequenz, verfahren zu deren herstellung sowie deren verwendung zum nachweis von nucleinsaeuren |
ES8706823A1 (es) | 1985-03-28 | 1987-06-16 | Cetus Corp | Un procedimiento para detectar la presencia o ausencia de al menos una secuencia especifica de acidos nucleicos en una muestra |
DE3813278A1 (de) | 1988-01-12 | 1989-07-20 | Boehringer Mannheim Gmbh | Verfahren zum nachweis von nukleinsaeuren |
EP0679716A4 (en) * | 1993-11-12 | 1999-06-09 | Kenichi Matsubara | GENE SIGNATURE. |
US5650415A (en) * | 1995-06-07 | 1997-07-22 | Sugen, Inc. | Quinoline compounds |
EP0876483A1 (en) * | 1996-01-26 | 1998-11-11 | HSC Research and Development Limited Partnership | Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
WO2000060080A2 (en) * | 1999-04-05 | 2000-10-12 | Incyte Pharmaceuticals, Inc. | Molecules of the immune system |
AU5047800A (en) * | 1999-05-28 | 2000-12-18 | Ludwig Institute For Cancer Research | Breast, gastric and prostate cancer associated antigens and uses therefor |
-
1998
- 1998-12-03 EP EP98122992A patent/EP1006184A1/en not_active Withdrawn
-
1999
- 1999-11-25 CH CH02154/99A patent/CH694204A5/de not_active IP Right Cessation
- 1999-12-01 CA CA002289914A patent/CA2289914C/en not_active Expired - Fee Related
- 1999-12-01 GB GB9928450A patent/GB2347930B/en not_active Expired - Fee Related
- 1999-12-01 FR FR9915143A patent/FR2788783B1/fr not_active Expired - Fee Related
- 1999-12-02 SE SE9904389A patent/SE523013C2/sv not_active IP Right Cessation
- 1999-12-02 US US09/453,195 patent/US6368826B1/en not_active Expired - Fee Related
- 1999-12-02 DE DE19958198A patent/DE19958198B4/de not_active Expired - Fee Related
- 1999-12-02 IT IT1999MI002519A patent/IT1314250B1/it active
- 1999-12-02 DE DE19964268A patent/DE19964268B4/de not_active Expired - Fee Related
- 1999-12-02 JP JP34299599A patent/JP3294575B2/ja not_active Expired - Fee Related
- 1999-12-02 DE DE19964269A patent/DE19964269B4/de not_active Expired - Fee Related
- 1999-12-03 NL NL1013748A patent/NL1013748C2/nl not_active IP Right Cessation
- 1999-12-03 AU AU63059/99A patent/AU728102B2/en not_active Ceased
- 1999-12-03 BE BE9900789A patent/BE1013527A3/fr not_active IP Right Cessation
-
2000
- 2000-12-06 JP JP2000371283A patent/JP2001218599A/ja not_active Withdrawn
-
2001
- 2001-07-30 US US09/917,974 patent/US6913883B2/en not_active Expired - Fee Related
-
2003
- 2003-06-18 SE SE0301757A patent/SE526919C8/sv not_active IP Right Cessation
-
2004
- 2004-06-14 US US10/867,045 patent/US7329734B2/en not_active Expired - Fee Related
- 2004-06-14 US US10/867,039 patent/US7202058B2/en not_active Expired - Fee Related
-
2005
- 2005-10-18 US US11/252,663 patent/US20060040358A1/en not_active Abandoned
-
2007
- 2007-09-13 US US11/854,663 patent/US20090018312A1/en not_active Abandoned
-
2009
- 2009-08-12 JP JP2009187299A patent/JP4638549B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE526919C8 (sv) | Nukleinsyra (IIP) som kodar för en IGF-1 receptorbindande polypeptid samt användning därav i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera föreningar som inhiberar interaktionen mellan IIP-1 och IGF-1R | |
DK1005488T4 (da) | Receptor som binder TRAIL | |
IL134537A0 (en) | Nucleic acid encoding an april ligand or a fragment thereof, vectors and host cells containing the same and methods for the production thereof | |
ATE365563T1 (de) | Verfahren zur schrittweise bindung von polyethylenglykol (peg) an polypeptide | |
DK591484A (da) | Fremgangsmaade til detektering af en bestemt polynucleotidsekvens i en testproeve indeholdende enkeltstrengede nucleinsyrer samt reagenssystem til anvendelse ved fremgangsmaaden | |
DE3768652D1 (de) | Verfahren zur erfassung von fehlern in oberflaechen. | |
NO306949B1 (no) | Azacykliske eller azabicykliske forbindelser samt farmasoeytiske preparater inneholdende slike forbindelser | |
DE69823078D1 (de) | System und Verfahren zur Verwaltung von Arbeitsgruppendruckern | |
EP1024360A3 (en) | Electrophoresis scanner for high-capacity capillary array | |
BR9306580A (pt) | Xilanase molécula de dna isolda ou recombinada codificando umaxilanase sequência de dna célula hospedeira uso de uma xilanase e molécula de dna isolada ou recombinante | |
DE69824178D1 (de) | Verfahren zur specifischen bestimmung der c-peptide | |
DK4387D0 (da) | Human-praepo-insulinlignende-vaerkstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne | |
BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
BR9704857A (pt) | Construções de ácido nucleico contendo promotores híbridos para uso em terapia de gene | |
DK591984D0 (da) | Fremgangsmaade til detektering af en bestemt polynucleotidsekvens i en testproeve indeholdende enkeltstrengede nucleinsyrer samt reagenssystem til anvendelse ved fremgangsmaaden | |
DK591684A (da) | Fremgangsmaade til detektering af en bestemt polynucleotidsekvens i en testproeve indeholdende enkeltstrengede nucleinsyrer samt reagenssystem til anvendelse ved fremgangsmaaden | |
DE69213891D1 (de) | Kontakt-Komposit zur Messung von elektrostatischen Spannungen | |
NO962084L (no) | DNA sekvens som koder for en BMP reseptor | |
DE69826458D1 (de) | Verfahren zum sequenzierung von dna | |
DE69806427D1 (de) | Verfahren zum Erfassen von Hämatopoetischen Vorläuferzellen | |
DE3680386D1 (de) | Verfahren zum fehlernachweis in duennen schichten auf keramiksubstrat. | |
FI962044A (sv) | DNA-sekvenser som kodar karboxipeptidas B i bukspottkörteln hos gris | |
DE59804729D1 (de) | Messanordnung zur elektrisch entkoppelten funktionsüberprüfung von im betrieb befindlichen systemen | |
AU8886798A (en) | Method for detecting highly functional polypeptides or nucleic acids | |
SE9500589D0 (sv) | Single nucleic acid base detection on solid substrates in single molecule DNA sequencing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |